Home > Journals > International Angiology > Past Issues > Articles online first > International Angiology 2018 Jan 11

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

INTERNATIONAL ANGIOLOGY

A Journal on Angiology


Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,37


eTOC

 

International Angiology 2018 Jan 11

DOI: 10.23736/S0392-9590.18.03897-X

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Peripheral arterial occlusive disease and perioperative risk

Peter POREDOS 1 , Pavel POREDOS 2

1 Department of Anaesthesiology and Perioperative Intensive Care, University Medical Centre Ljubljana, Ljubljana, Slovenia; 2 Department of Vascular Disease, University Medical Centre Ljubljana, Ljubljana, Slovenia


PDF  


Surgical procedures represent a risk for different complications which may appear during the perioperative period. Cardiac ischemic events and vascular complications are the most important causes of increased morbidity and mortality and they are much more frequent in patients with manifest cardiovascular disease. This is particularly seen in patients with peripheral arterial occlusive disease (PAD), which represents advanced atherosclerosis frequently accompanied by the presence of coronary artery disease. Therefore, patients with PAD need careful preoperative examination, including estimation of functional capacity and the presence of other co-existing atherosclerotic diseases. The perioperative risk of cardiac complications should be calculated by Apgar score. In patients with unstable coronary syndrome myocardial revascularization should be performed before vascular procedures, whereas in other coronary patients pharmacotherapy should be intensified. The latter includes beta-adrenergic receptor blockers, statin therapy, which significantly improves postoperative outcome and antiplatelet drugs, which do not significantly increase major bleeding complications but significantly reduce cardiovascular thromboembolic events. Postoperative strategy for prevention of complications should be focused particularly on identification of myocardial infarction which is frequently asymptomatic. Therefore, serial postoperative measurements of troponin levels allow close monitoring of postoperative myocardial damage and help to implement strategic choices for the treatment of postoperative adverse cardiac events.


KEY WORDS: Perioperative ischemic heart complications - Preoperative examination - Drugs for reducing preoperative risk - Postoperative monitoring of ischemic heart events

top of page

Publication History

Article first published online: January 11, 2018
Manuscript accepted: January 4, 2018
Manuscript received: July 30, 2017

Cite this article as

Poredos P, Poredos P. Peripheral arterial occlusive disease and perioperative risk. Int Angiol 2018 Jan 10. DOI: 10.23736/S0392-9590.18.03897-X

Corresponding author e-mail

peter.poredos@kclj.si